Simpson Thacher Represents Underwriters in IPO of BioAmber Inc.
05.15.13
This is only gets display when printing
Simpson Thacher recently represented the underwriters, led by joint bookrunners Credit Suisse Securities (USA) LLC, Barclays Capital Inc. and Société Générale, in the initial public offering by BioAmber Inc. of an aggregate of 8,000,000 units, each unit consisting of one share of BioAmber’s common stock and one warrant to purchase half of one share of common stock. BioAmber’s units are listed on the NYSE under the symbol “BIOA.U”. The common stock and warrants comprising the units will begin trading separately on the NYSE under the symbols “BIOA” and “BIOA.WS”, respectively, on Monday, June 10, 2013 at which time trading of the units will be suspended and the units will be delisted. BioAmber also intends to list its common stock on the Professional Segment of the regulated market of NYSE Euronext in Paris under the symbol “BIOA.”
BioAmber is a next-generation chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are cost-competitive replacements for petroleum-derived chemicals. These chemicals can be used to manufacture a wide variety of everyday products, including plastics, food additives and personal care products.
The Simpson Thacher team included Ryan Bekkerus, Edgar Lewandowski, Jo Djekovic, Lauren Yoon and Joo Hyun Lee (Capital Markets); Jodi Sackel (Tax); Jamin Koslowe and Doug Tang (Executive Compensation and Employee Benefits); Genevieve Dorment (Intellectual Property); Michael Isby (Environmental); and Jennie Getsin (FINRA and Blue Sky).